Clinical development of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) Meeting Abstract
| Authors: | O'Connor, O. A.; Kelly, W.; Wang, E. S.; Richon, V.; Moskowitz, C.; Tong, W.; Donnelly, G.; Zelenetz, A. D.; Moore, M. A. S.; Rifkind, R. A.; Marks, P. A. |
| Abstract Title: | Clinical development of the histone deacetylase inhibitor suberoylanalide hydroxamic acid (SAHA) in aggressive non-Hodgkin's lymphoma (NHL) and Hodgkin's disease (HD) |
| Meeting Title: | 43rd Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 98 |
| Issue: | 11 Pt. 1 |
| Meeting Dates: | 2001 Dec 7-11 |
| Meeting Location: | Orlando, FL |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2001-11-16 |
| Start Page: | 611a |
| Language: | English |
| ACCESSION: | WOS:000172134102569 |
| PROVIDER: | wos |
| PUBMED: | 11727739 |
| Notes: | Meeting Abstract: 2562 -- Source: Wos |
